Clinical significance of pre-S1 of HBV in several common HBV infection models
Yanlong Yang
Abstract
Yanlong Yang
Abstract
Objective:To investigate the clinical significance of pre-S1 of HBV in several common HBV infection models.Method: Pre-S1,HBV-DNA and the serum markers of HBV were measured in 353 HBV patients and 50 controls.Result:The positive rates of pre-S1 and HBV-DNA were 85.7% and 87.8% in the HBsAg(+)、HBeAg(+)、HBcAb(+) model,53.9%and 49.4%in the HBsAg(+)、HBcAb(+)、HBeAb(+)model,78.3%and 80.0%in the HBsAg(+)、HBeAg(+) model,28.6%and 24.5%in the HBsAg(+)、HBcAb(+) model,16.7%and 0.0%in the HBsAg(+)、HBeAg(+)、HBeAb(+) model,0.0%and 0.0% in others.Conclusion: Pre-S1 of HBV may be used as a reliable marker of HBV replication in vivo.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the clinical significance of pre-S1 of HBV in several common HBV infection models.Method: Pre-S1,HBV-DNA and the serum markers of HBV were measured in 353 HBV patients and 50 controls.Result:The positive rates of pre-S1 and HBV-DNA were 85.7% and 87.8% in the HBsAg(+)、HBeAg(+)、HBcAb(+) model,53.9%and 49.4%in the HBsAg(+)、HBcAb(+)、HBeAb(+)model,78.3%and 80.0%in the HBsAg(+)、HBeAg(+) model,28.6%and 24.5%in the HBsAg(+)、HBcAb(+) model,16.7%and 0.0%in the HBsAg(+)、HBeAg(+)、HBeAb(+) model,0.0%and 0.0% in others.Conclusion: Pre-S1 of HBV may be used as a reliable marker of HBV replication in vivo.
Key concepts: HBsAg, HBeAg, Medicine, Hepatitis B virus, Virology, Clinical significance, Immunology, Internal medicine